| Name |
Dobutamin Panpharma 12,5 mg/ml koncentrat za otopinu za infuziju |
| Marketing Authorisation Number |
HR-H-370945343 |
| Active Substance |
dobutaminklorid |
| Composition |
1 ml koncentrata za otopinu za infuziju sadrži 12,5 mg dobutamina u obliku dobutaminklorida |
| Pharmaceutical Form |
Koncentrat za otopinu za infuziju |
| Manufacturer |
Panpharma GmbH, Trittau, Njemačka |
| Marketing Authorisation Holder |
Panpharma, Z.I. du Clairay, Luitre, Francuska |
| Marketing Authorisation Date |
16.07.2025 |
| MA Period of Validity |
16.07.2030 |
| Classification Number |
UP/I-530-09/23-01/379 |
| Registration Number |
381-12-01/286-25-10 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
C01CA07 |
| Marketing status |
Never marketed |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |